These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 19383238)
1. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. Bekci TT; Senol T; Maden E J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy. Bozkurt M; Yumru AE; Aral I Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047 [TBL] [Abstract][Full Text] [Related]
3. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
5. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers. Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854 [TBL] [Abstract][Full Text] [Related]
7. Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays. Dolscheid-Pommerich RC; Manekeller S; Walgenbach-Brünagel G; Kalff JC; Hartmann G; Wagner BS; Holdenrieder S Anticancer Res; 2017 Jan; 37(1):353-359. PubMed ID: 28011514 [TBL] [Abstract][Full Text] [Related]
8. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study. Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
11. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading. Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060 [TBL] [Abstract][Full Text] [Related]
12. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma. Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161 [TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma. Uçkaya G; Ozet A; Arpaci A; Kömürcü S Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. Wang YR; Yan JX; Wang LN J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941 [TBL] [Abstract][Full Text] [Related]
15. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites. Zhu FL; Ling AS; Wei Q; Ma J; Lu G Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514 [TBL] [Abstract][Full Text] [Related]
16. [1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center]. Pecking AP; Mechelany-Corone C; Pichon MF Pathol Biol (Paris); 2000 Nov; 48(9):819-24. PubMed ID: 11141917 [TBL] [Abstract][Full Text] [Related]
17. [A patient with gastric cancer accompanied by high levels of serum AFP, CEA, CA19-9 and CA125]. Toyota M; Ochi K; Minami T; Ohmori Y; Nakanishi T; Tsujimura T Nihon Shokakibyo Gakkai Zasshi; 2000 Apr; 97(4):426-31. PubMed ID: 10793564 [No Abstract] [Full Text] [Related]
18. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study. Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy. Huo YR; Huang Y; Liauw W; Zhao J; Morris DL Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]